DJ Novavax Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 6.35% to $5.60 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 5.97% to 16,550.61 and Dow Jones Industrial Average falling 3.98% to 40,545.93.
This was the stock's eighth consecutive day of losses.
Novavax Inc. closed 76.53% short of its 52-week high of $23.86, which the company achieved on June 6th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 2.87% to $159.82, Pfizer Inc. $(PFE)$ fell 1.66% to $24.29, and Merck & Co. Inc. $(MRK)$ fell 0.24% to $86.39.
Trading volume (6.2 M) eclipsed its 50-day average volume of 4.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 03, 2025 17:26 ET (21:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。